Leadership Change at Recursion Raises Questions About AI in Drug Development
Recursion Pharmaceuticals undergoes a leadership change amid AI challenges.
Tag: pharmaceuticals
Norway’s Wealth Fund Opposes Board Changes at Novo Nordisk
Norway’s wealth fund is opposing changes to Novo Nordisk’s board.
US Pharma Policy Changes and Their Global Implications
U.S. pharmaceutical policy changes impact global markets significantly.
Bristol-Myers Squibb Faces Market Misvaluation Despite Strong Earnings
Bristol-Myers Squibb’s strong earnings highlight market misvaluation.
Eli Lilly Prepares for Potential Growth in Upcoming Quarter
Eli Lilly is poised for potential growth in the upcoming quarter.
Trump Administration Considers Quantum Investments as Alphabet Stays in Focus
The Trump administration is exploring quantum technology investments.